{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:42:54Z","timestamp":1790833374282,"version":"4.1.0"},"reference-count":193,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 ZIA BC010778-13"],"award-info":[{"award-number":["1 ZIA BC010778-13"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Since the emergence of HIV and AIDS in the early 1980s, the development of safe and effective therapies has accompanied a massive increase in our understanding of the fundamental processes that drive HIV biology. As basic HIV research has informed the development of novel therapies, HIV inhibitors have been used as probes for investigating basic mechanisms of HIV-1 replication, transmission, and pathogenesis. This positive feedback cycle has led to the development of highly effective combination antiretroviral therapy (cART), which has helped stall the progression to AIDS, prolong lives, and reduce transmission of the virus. However, to combat the growing rates of virologic failure and toxicity associated with long-term therapy, it is important to diversify our repertoire of HIV-1 treatments by identifying compounds that block additional steps not targeted by current drugs. Most of the available therapeutics disrupt early events in the replication cycle, with the exception of the protease (PR) inhibitors, which act at the virus maturation step. HIV-1 maturation consists of a series of biochemical changes that facilitate the conversion of an immature, noninfectious particle to a mature infectious virion. These changes include proteolytic processing of the Gag polyprotein by the viral protease (PR), structural rearrangement of the capsid (CA) protein, and assembly of individual CA monomers into hexamers and pentamers that ultimately form the capsid. Here, we review the development and therapeutic potential of maturation inhibitors (MIs), an experimental class of anti-HIV-1 compounds with mechanisms of action distinct from those of the PR inhibitors. We emphasize the key insights into HIV-1 biology and structure that the study of MIs has provided. We will focus on three distinct groups of inhibitors that block HIV-1 maturation: (1) compounds that block the processing of the CA-spacer peptide 1 (SP1) cleavage intermediate, the original class of compounds to which the term MI was applied; (2) CA-binding inhibitors that disrupt capsid condensation; and (3) allosteric integrase inhibitors (ALLINIs) that block the packaging of the viral RNA genome into the condensing capsid during maturation. Although these three classes of compounds have distinct structures and mechanisms of action, they share the ability to block the formation of the condensed conical capsid, thereby blocking particle infectivity.<\/jats:p>","DOI":"10.3390\/v12090940","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T09:05:37Z","timestamp":1598432737000},"page":"940","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["HIV-1 Maturation: Lessons Learned from Inhibitors"],"prefix":"10.3390","volume":"12","author":[{"given":"Alex B.","family":"Kleinpeter","sequence":"first","affiliation":[{"name":"HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric O.","family":"Freed","sequence":"additional","affiliation":[{"name":"HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"a006866","DOI":"10.1101\/cshperspect.a006866","article-title":"Hiv: Cell binding and entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrmicro3503","article-title":"HIV-1 capsid: The multifaceted key player in HIV-1 infection","volume":"13","author":"Campbell","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/331280a0","article-title":"Characterization of ribosomal frameshifting in HIV-1 gag-pol expression","volume":"331","author":"Jacks","year":"1988","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.tim.2019.04.003","article-title":"RNA Packaging in HIV","volume":"27","author":"Rein","year":"2019","journal-title":"Trends Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"a006924","DOI":"10.1101\/cshperspect.a006924","article-title":"HIV-1 assembly, budding, and maturation","volume":"2","author":"Sundquist","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature09640","article-title":"Atomic-level modelling of the HIV capsid","volume":"469","author":"Pornillos","year":"2011","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrmicro3490","article-title":"HIV-1 assembly, release and maturation","volume":"13","author":"Freed","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2215\/CJN.02240218","article-title":"Clinical Pharmacology in HIV Therapy","volume":"14","author":"Atta","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_9","unstructured":"Kemnic, T.R., and Gulick, P.G. (2020). HIV Antiretroviral Therapy. StatPearls, StatPearls Publishing."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tim.2012.11.006","article-title":"HIV Gag polyprotein: Processing and early viral particle assembly","volume":"21","author":"Bell","year":"2013","journal-title":"Trends Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1146\/annurev-virology-031413-085427","article-title":"In Vitro Assembly of Retroviruses","volume":"1","author":"Bush","year":"2014","journal-title":"Annu. Rev. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"40867","DOI":"10.1074\/jbc.R112.399444","article-title":"The choreography of HIV-1 proteolytic processing and virion assembly","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coviro.2019.05.004","article-title":"Maturation of retroviruses","volume":"36","author":"Pornillos","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.coviro.2016.02.008","article-title":"Retrovirus maturation\u2014An extraordinary structural transformation","volume":"18","author":"Mattei","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"10226","DOI":"10.1128\/JVI.76.20.10226-10233.2002","article-title":"Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease","volume":"76","author":"Pettit","year":"2002","journal-title":"J. Virol."},{"key":"ref_16","unstructured":"James, M.N.G. (1998). The Regulation of Sequential Processing of HIV-1 Gag by the Viral Protease. Aspartic Proteinases: Retroviral and Cellular Enzymes, Springer."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"14539","DOI":"10.1016\/S0021-9258(18)98720-X","article-title":"Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid","volume":"266","author":"Pettit","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"29692","DOI":"10.1074\/jbc.M109.027144","article-title":"HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity","volume":"284","author":"Anders","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virol.2010.01.028","article-title":"The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation","volume":"400","author":"Checkley","year":"2010","journal-title":"Virology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s41467-017-01856-y","article-title":"Quenching protein dynamics interferes with HIV capsid maturation","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e17063","DOI":"10.7554\/eLife.17063","article-title":"Crystal structure of an HIV assembly and maturation switch","volume":"5","author":"Wagner","year":"2016","journal-title":"eLife"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1126\/science.aaf9620","article-title":"An atomic model of HIV-1 capsid-SP1 reveals structures regulating assembly and maturation","volume":"353","author":"Schur","year":"2016","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"E9401","DOI":"10.1073\/pnas.1811237115","article-title":"High-resolution structures of HIV-1 Gag cleavage mutants determine structural switch for virus maturation","volume":"115","author":"Mattei","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"13655","DOI":"10.1128\/JVI.01408-13","article-title":"A two-pronged structural analysis of retroviral maturation indicates that core formation proceeds by a disassembly-reassembly pathway rather than a displacive transition","volume":"87","author":"Keller","year":"2013","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1126\/science.273.5272.231","article-title":"Structure of the Amino-Terminal Core Domain of the HIV-1 Capsid Protein","volume":"273","author":"Gitti","year":"1996","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/emboj\/17.6.1555","article-title":"Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly","volume":"17","author":"Stemmler","year":"1998","journal-title":"Embo J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jmb.2004.11.064","article-title":"Three-dimensional Structure of HIV-1 Virus-like Particles by Electron Cryotomography","volume":"346","author":"Benjamin","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1128\/jvi.69.5.2729-2736.1995","article-title":"Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication","volume":"69","author":"Engelman","year":"1995","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"9765","DOI":"10.1128\/JVI.01522-15","article-title":"Distribution and Redistribution of HIV-1 Nucleocapsid Protein in Immature, Mature, and Integrase-Inhibited Virions: A Role for Integrase in Maturation","volume":"89","author":"Fontana","year":"2015","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1073\/pnas.1300703110","article-title":"Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation","volume":"110","author":"Jurado","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2016.07.044","article-title":"HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis","volume":"166","author":"Kessl","year":"2016","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.aaa5936","article-title":"X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability","volume":"349","author":"Gres","year":"2015","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2009.04.063","article-title":"X-ray structures of the hexameric building block of the HIV capsid","volume":"137","author":"Pornillos","year":"2009","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.aah4972","article-title":"The structure and flexibility of conical HIV-1 capsids determined within intact virions","volume":"354","author":"Mattei","year":"2016","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Di Nunzio, F., Danckaert, A., Fricke, T., Perez, P., Fernandez, J., Perret, E., Roux, P., Shorte, S., Charneau, P., and Diaz-Griffero, F. (2012). Human Nucleoporins Promote HIV-1 Docking at the Nuclear Pore, Nuclear Import and Integration. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046037"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.chom.2018.03.009","article-title":"Single HIV-1 Imaging Reveals Progression of Infection through CA-Dependent Steps of Docking at the Nuclear Pore, Uncoating, and Nuclear Transport","volume":"23","author":"Francis","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1073\/pnas.1920631117","article-title":"HIV-1 uncoats in the nucleus near sites of integration","volume":"117","author":"Burdick","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41564-020-0735-8","article-title":"Nuclear pore blockade reveals that HIV-1 completes reverse transcription and uncoating in the nucleus","volume":"5","author":"Dharan","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1128\/JVI.76.11.5667-5677.2002","article-title":"Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication","volume":"76","author":"Forshey","year":"2002","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.chom.2010.02.007","article-title":"Flexible use of nuclear import pathways by HIV-1","volume":"7","author":"Lee","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Price, A.J., Fletcher, A.J., Schaller, T., Elliott, T., Lee, K., KewalRamani, V.N., Chin, J.W., Towers, G.J., and James, L.C. (2012). CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog., 8.","DOI":"10.2210\/pdb4b4n\/pdb"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1128\/JVI.00325-11","article-title":"The Requirement for Nucleoporin NUP153 during Human Immunodeficiency Virus Type 1 Infection Is Determined by the Viral Capsid","volume":"85","author":"Matreyek","year":"2011","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Matreyek, K.A., Y\u00fccel, S.S., Li, X., and Engelman, A. (2013). Nucleoporin NUP153 Phenylalanine-Glycine Motifs Engage a Common Binding Pocket within the HIV-1 Capsid Protein to Mediate Lentiviral Infectivity. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003693"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.chom.2018.08.002","article-title":"Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration","volume":"24","author":"Achuthan","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1074\/jbc.M209278200","article-title":"HIV-1 integrase forms stable tetramers and associates with LEDGF\/p75 protein in human cells","volume":"278","author":"Cherepanov","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"33528","DOI":"10.1074\/jbc.M303594200","article-title":"LEDGF\/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells","volume":"278","author":"Maertens","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"18625","DOI":"10.1073\/pnas.1419945112","article-title":"Structural basis of HIV-1 capsid recognition by PF74 and CPSF6","volume":"111","author":"Bhattacharya","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Price, A.J., Jacques, D.A., McEwan, W.A., Fletcher, A.J., Essig, S., Chin, J.W., Halambage, U.D., Aiken, C., and James, L.C. (2014). Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004459"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-018-0396-4","article-title":"Inositol phosphates are assembly co-factors for HIV-1","volume":"560","author":"Dick","year":"2018","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1016\/j.celrep.2019.11.050","article-title":"Cellular IP6 Levels Limit HIV Production while Viruses that Cannot Efficiently Package IP6 Are Attenuated for Infection and Replication","volume":"29","author":"Mallery","year":"2019","journal-title":"Cell Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e35335","DOI":"10.7554\/eLife.35335","article-title":"IP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis","volume":"7","author":"Mallery","year":"2018","journal-title":"eLife"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Xu, C., Fischer, D.K., Rankovic, S., Li, W., Dick, R., Runge, B., Zadorozhnyi, R., Ahn, J., Aiken, C., and Polenova, T. (2020). Permeability of the HIV-1 capsid to metabolites modulates viral DNA synthesis. bioRxiv.","DOI":"10.1101\/2020.04.30.071217"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1021\/np50104a008","article-title":"Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids","volume":"57","author":"Fujioka","year":"1994","journal-title":"J. Nat. Prod."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1021\/jm950922q","article-title":"Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents","volume":"39","author":"Kashiwada","year":"1996","journal-title":"J. Med. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/AAC.45.4.1225-1230.2001","article-title":"Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation","volume":"45","author":"Kanamoto","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"13555","DOI":"10.1073\/pnas.2234683100","article-title":"PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing","volume":"100","author":"Li","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-4690-1-15","article-title":"The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3\u2019,3\u2019-dimethylsuccinyl}-betulinic acid","volume":"1","author":"Zhou","year":"2004","journal-title":"Retrovirology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1128\/JVI.78.2.922-929.2004","article-title":"Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation","volume":"78","author":"Zhou","year":"2004","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1128\/JVI.01369-06","article-title":"In Vitro Resistance to the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PA-457 (Bevirimat)","volume":"80","author":"Adamson","year":"2006","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1128\/JVI.02743-05","article-title":"3-O-(3\u2032,3\u2032-Dimethysuccinyl) Betulinic Acid Inhibits Maturation of the Human Immunodeficiency Virus Type 1 Gag Precursor Assembled In Vitro","volume":"80","author":"Sakalian","year":"2006","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"42149","DOI":"10.1074\/jbc.M508951200","article-title":"Inhibition of HIV-1 maturation via drug association with the viral Gag protein in immature HIV-1 particles","volume":"280","author":"Zhou","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"12095","DOI":"10.1128\/JVI.01626-06","article-title":"Human immunodeficiency virus type 1 resistance to the small molecule maturation inhibitor 3-O-(3\u2019,3\u2019-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in Gag","volume":"80","author":"Zhou","year":"2006","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Lin, Z., Cantone, J., Lu, H., Nowicka-Sans, B., Protack, T., Yuan, T., Yang, H., Liu, Z., Drexler, D., and Regueiro-Ren, A. (2016). Mechanistic Studies and Modeling Reveal the Origin of Differential Inhibition of Gag Polymorphic Viruses by HIV-1 Maturation Inhibitors. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005990"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1742-4690-8-101","article-title":"The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles","volume":"8","author":"Nguyen","year":"2011","journal-title":"Retrovirology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/AAC.00759-09","article-title":"New Small-Molecule Inhibitor Class Targeting Human Immunodeficiency Virus Type 1 Virion Maturation","volume":"53","author":"Blair","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Waki, K., Durell, S.R., Soheilian, F., Nagashima, K., Butler, S.L., and Freed, E.O. (2012). Structural and Functional Insights into the HIV-1 Maturation Inhibitor Binding Pocket. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002997"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.1128\/JVI.01075-16","article-title":"Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396","volume":"90","author":"Murgatroyd","year":"2016","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0022-2836(03)00289-4","article-title":"Antiviral Inhibition of the HIV-1 Capsid Protein","volume":"327","author":"Tang","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nsmb964","article-title":"A peptide inhibitor of HIV-1 assembly in vitro","volume":"12","author":"Sticht","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Blair, W.S., Pickford, C., Irving, S.L., Brown, D.G., Anderson, M., Bazin, R., Cao, J., Ciaramella, G., Isaacson, J., and Jackson, L. (2010). HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001220"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41591-019-0560-x","article-title":"A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model","volume":"25","author":"Yant","year":"2019","journal-title":"Nat. Med."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Link, J.O., Rhee, M.S., Tse, W.C., Zheng, J., Somoza, J.R., Rowe, W., Begley, R., Chiu, A., Mulato, A., and Hansen, D. (2020). Clinical targeting of HIV capsid protein with a long-acting small molecule. Nature.","DOI":"10.1038\/s41586-020-2443-1"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"20477","DOI":"10.1074\/jbc.M114.551119","article-title":"Allosteric inhibition of human immunodeficiency virus integrase: Late block during viral replication and abnormal multimerization involving specific protein domains","volume":"289","author":"Gupta","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JVI.72.4.2846-2854.1998","article-title":"Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites","volume":"72","author":"Wiegers","year":"1998","journal-title":"J. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1128\/JVI.01926-10","article-title":"HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice","volume":"85","author":"Keller","year":"2011","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/JVI.02204-15","article-title":"Identification of an HIV-1 Mutation in Spacer Peptide 1 That Stabilizes the Immature CA-SP1 Lattice","volume":"90","author":"Fontana","year":"2016","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1128\/JVI.72.3.2072-2078.1998","article-title":"A Putative \u03b1-Helical Structure Which Overlaps the Capsid-p2 Boundary in the Human Immunodeficiency Virus Type 1 Gag Precursor Is Crucial for Viral Particle Assembly","volume":"72","author":"Accola","year":"1998","journal-title":"J. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"11729","DOI":"10.1128\/JVI.76.22.11729-11737.2002","article-title":"Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag","volume":"76","author":"Liang","year":"2002","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1110\/ps.041087605","article-title":"Helical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2: Implications for particle assembly and RNA packaging","volume":"14","author":"Morellet","year":"2005","journal-title":"Protein Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/sj.emboj.7601664","article-title":"Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells","volume":"26","author":"Wright","year":"2007","journal-title":"Embo J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"13258","DOI":"10.1073\/pnas.1806806115","article-title":"MicroED structures of HIV-1 Gag CTD-SP1 reveal binding interactions with the maturation inhibitor bevirimat","volume":"115","author":"Purdy","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","unstructured":"Mendonca, L., Sun, D., Ning, J., Liu, J., Mateusz, O., Himes, B., and Zhang, P. (2020, January 18\u201321). A dynamic CA-SP1 six-helix bundle dictates HIV-1 maturation. Proceedings of the Cold Spring Harbor\u2014Retroviruses, Abstract #142, Cold Spring Harbor, NY, USA."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"10286","DOI":"10.1073\/pnas.1917755117","article-title":"Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles","volume":"117","author":"Gupta","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Dicker, I., Zhang, S., Ray, N., Beno, B.R., Regueiro-Ren, A., Joshi, S., Cockett, M., Krystal, M., and Lataillade, M. (2019). Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0224076"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/acsmedchemlett.8b00656","article-title":"Second Generation Inhibitors of HIV-1 Maturation","volume":"10","author":"Dicker","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.antiviral.2019.02.014","article-title":"Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation","volume":"164","author":"Neyret","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1742-4690-7-36","article-title":"Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1maturation inhibitor bevirimat","volume":"7","author":"Adamson","year":"2010","journal-title":"Retrovirology"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Urano, E., Timilsina, U., Kaplan, J.A., Ablan, S., Ghimire, D., Pham, P., Kuruppu, N., Mandt, R., Durell, S.R., and Nitz, T.J. (2019). Resistance to Second-Generation HIV-1 Maturation Inhibitors. J. Virol., 93.","DOI":"10.1128\/JVI.02017-18"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Kucharska, I., Ding, P., Zadrozny, K.K., Dick, R.A., Summers, M.F., Ganser-Pornillos, B.K., and Pornillos, O. (2020). Biochemical Reconstitution of HIV-1 Assembly and Maturation. J. Virol., 94.","DOI":"10.1128\/JVI.01844-19"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/095632020801900301","article-title":"Bevirimat: A Novel Maturation Inhibitor for the Treatment of HIV-1 Infection","volume":"19","author":"Martin","year":"2008","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AAC.01784-09","article-title":"Phenotypic susceptibility to bevirimat in isolates from HIV-1-infected patients without prior exposure to bevirimat","volume":"54","author":"Margot","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.01650-08","article-title":"Susceptibility of Human Immunodeficiency Virus Type 1 to the Maturation Inhibitor Bevirimat Is Modulated by Baseline Polymorphisms in Gag Spacer Peptide 1","volume":"53","author":"Salzwedel","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1128\/AAC.00152-07","article-title":"Phase I and II Study of the Safety, Virologic Effect, and Pharmacokinetics\/Pharmacodynamics of Single-Dose 3-O-(3\u2032,3\u2032-Dimethylsuccinyl) Betulinic Acid (Bevirimat) against Human Immunodeficiency Virus Infection","volume":"51","author":"Smith","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1021\/jm3016969","article-title":"New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1","volume":"56","author":"Dang","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1016\/j.bmcl.2012.06.080","article-title":"Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants","volume":"22","author":"Dang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"8128","DOI":"10.1021\/jm301040s","article-title":"Anti-AIDS agents 90. novel C-28 modified bevirimat analogues as potent HIV maturation inhibitors","volume":"55","author":"Qian","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1128\/AAC.02121-15","article-title":"Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors","volume":"60","author":"Urano","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.bmc.2016.03.001","article-title":"C-3 benzoic acid derivatives of C-3 deoxybetulinic acid and deoxybetulin as HIV-1 maturation inhibitors","volume":"24","author":"Liu","year":"2016","journal-title":"Bioorganic Med. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejmech.2013.01.013","article-title":"Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site","volume":"62","author":"Coric","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1128\/AAC.02560-15","article-title":"Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage","volume":"60","author":"Protack","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/cid\/cix239","article-title":"Antiviral Activity, Safety, and Exposure\u2013Response Relationships of GSK3532795, a Second-Generation Human Immunodeficiency Virus Type 1 Maturation Inhibitor, Administered as Monotherapy or in Combination With Atazanavir With or Without Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled Trial (AI468002)","volume":"65","author":"Hwang","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/QAI.0000000000001304","article-title":"The Second-Generation Maturation Inhibitor GSK3532795 Maintains Potent Activity Toward HIV Protease Inhibitor\u2013Resistant Clinical Isolates","volume":"75","author":"Ray","year":"2017","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Morales-Ramirez, J., Bogner, J.R., Molina, J.M., Lombaard, J., Dicker, I.B., Stock, D.A., DeGrosky, M., Gartland, M., Pene Dumitrescu, T., and Min, S. (2018). Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir\/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0205368"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"8645","DOI":"10.1128\/jvi.70.12.8645-8652.1996","article-title":"The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle","volume":"70","author":"Reicin","year":"1996","journal-title":"J. Virol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1128\/JVI.72.5.4403-4407.1998","article-title":"Cryoelectron microscopic examination of human immunodeficiency virus type 1 virions with mutations in the cyclophilin A binding loop","volume":"72","author":"Kong","year":"1998","journal-title":"J. Virol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jmb.2007.07.070","article-title":"Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein","volume":"373","author":"Kelly","year":"2007","journal-title":"J. Mol. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nsmb967","article-title":"The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor","volume":"12","author":"Ternois","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1126\/science.278.5339.849","article-title":"Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein","volume":"278","author":"Gamble","year":"1997","journal-title":"Science"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0022-2836(02)01245-7","article-title":"Identification of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry","volume":"325","author":"Lanman","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1128\/JVI.77.9.5439-5450.2003","article-title":"Functional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein","volume":"77","author":"Stray","year":"2003","journal-title":"J. Virol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/JVI.78.5.2545-2552.2004","article-title":"Assembly Properties of the Human Immunodeficiency Virus Type 1 CA Protein","volume":"78","author":"Stray","year":"2004","journal-title":"J. Virol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1742-4690-10-136","article-title":"Dual-acting stapled peptides target both HIV-1 entry and assembly","volume":"10","author":"Zhang","year":"2013","journal-title":"Retrovirology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jmb.2008.02.066","article-title":"A cell-penetrating helical peptide as a potential HIV-1 inhibitor","volume":"378","author":"Zhang","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"10587","DOI":"10.1128\/JVI.01705-13","article-title":"Human cytosolic extracts stabilize the HIV-1 core","volume":"87","author":"Fricke","year":"2013","journal-title":"J. Virol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/JVI.01406-10","article-title":"Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization","volume":"85","author":"Shi","year":"2011","journal-title":"J. Virol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1128\/JVI.02634-06","article-title":"A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: Rescue by a second-site substitution in a distal region of CA","volume":"81","author":"Yang","year":"2007","journal-title":"J. Virol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Rankovic, S., Ramalho, R., Aiken, C., and Rousso, I. (2018). PF74 Reinforces the HIV-1 Capsid To Impair Reverse Transcription-Induced Uncoating. J. Virol., 92.","DOI":"10.1128\/JVI.00845-18"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"17076","DOI":"10.1038\/s41598-019-53483-w","article-title":"A simple, high-throughput stabilization assay to test HIV-1 uncoating inhibitors","volume":"9","author":"Kaufman","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e04114","DOI":"10.7554\/eLife.04114","article-title":"Quantitative microscopy of functional HIV post-entry complexes reveals association of replication with the viral capsid","volume":"3","author":"Peng","year":"2014","journal-title":"eLife"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.antiviral.2004.11.001","article-title":"A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors","volume":"65","author":"Blair","year":"2005","journal-title":"Antivir. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1128\/JVI.03116-15","article-title":"Roles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74","volume":"90","author":"Saito","year":"2016","journal-title":"J. Virol."},{"key":"ref_122","first-page":"1070","article-title":"Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action","volume":"5","author":"Xu","year":"2018","journal-title":"J. Drug Des. Res."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Vernekar, S.K.V., Sahani, R.L., Casey, M.C., Kankanala, J., Wang, L., Kirby, K.A., Du, H., Zhang, H., Tedbury, P.R., and Xie, J. (2020). Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules. Viruses, 12.","DOI":"10.3390\/v12040452"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"112085","DOI":"10.1016\/j.ejmech.2020.112085","article-title":"Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities","volume":"190","author":"Sun","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13543784.2020.1724281","article-title":"Combination therapies currently under investigation in phase I and phase II clinical trials for HIV-1","volume":"29","author":"Pham","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1128\/JVI.00493-12","article-title":"Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein","volume":"86","author":"Lemke","year":"2012","journal-title":"J. Virol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/cb400075f","article-title":"Novel Inhibitor Binding Site Discovery on HIV-1 Capsid N-Terminal Domain by NMR and X-ray Crystallography","volume":"8","author":"Goudreau","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1107\/S0907444913006409","article-title":"A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallization via compound-mediated dimerization","volume":"69","author":"Lemke","year":"2013","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Wang, W., Zhou, J., Halambage, U.D., Jurado, K.A., Jamin, A.V., Wang, Y., Engelman, A.N., and Aiken, C. (2017). Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein. J. Virol., 91.","DOI":"10.1128\/JVI.02155-16"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"39314","DOI":"10.1074\/jbc.M110.155275","article-title":"Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein","volume":"285","author":"Vozzolo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1128\/JVI.05006-11","article-title":"Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid","volume":"86","author":"Kortagere","year":"2012","journal-title":"J. Virol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1021\/ci500437r","article-title":"Structure-activity relationships of a novel capsid targeted inhibitor of HIV-1 replication","volume":"54","author":"Kortagere","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1128\/AAC.00985-13","article-title":"Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes","volume":"57","author":"Lamorte","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12977-014-0120-x","article-title":"BI-2 destabilizes HIV-1 cores during infection and Prevents Binding of CPSF6 to the HIV-1 Capsid","volume":"11","author":"Fricke","year":"2014","journal-title":"Retrovirology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1128\/AAC.02574-15","article-title":"Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication","volume":"60","author":"Brady","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"28961","DOI":"10.1039\/C9RA05869A","article-title":"Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors","volume":"9","author":"Jiang","year":"2019","journal-title":"RSC Adv."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Zhang, D.-W., Luo, R.-H., Xu, L., Yang, L.-M., Xu, X.-S., Zheng, Y.-T., and Luo, H. (2020). Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors. Int. J. Antimicrob. Agents, 105926.","DOI":"10.1016\/j.ijantimicag.2020.105926"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/35030177","article-title":"Image reconstructions of helical assemblies of the HIV-1 CA protein","volume":"407","author":"Li","year":"2000","journal-title":"Nature"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cell.2007.08.018","article-title":"Structure of full-length HIV-1 CA: A model for the mature capsid lattice","volume":"131","author":"Cheng","year":"2007","journal-title":"Cell"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"32024","DOI":"10.1074\/jbc.M804230200","article-title":"Residues in the HIV-1 capsid assembly inhibitor binding site are essential for maintaining the assembly-competent quaternary structure of the capsid protein","volume":"283","author":"Bartonova","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nsmb790","article-title":"Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange","volume":"11","author":"Lanman","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1128\/JVI.75.15.6850-6856.2001","article-title":"Second-Site Suppressors of Rous Sarcoma Virus CA Mutations: Evidence for Interdomain Interactions","volume":"75","author":"Bowzard","year":"2001","journal-title":"J. Virol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1128\/JVI.02219-14","article-title":"HIV-1 uncoating is facilitated by dynein and kinesin 1","volume":"88","author":"Lukic","year":"2014","journal-title":"J. Virol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.3390\/v6114195","article-title":"Cytoplasmic dynein promotes HIV-1 uncoating","volume":"6","author":"Pawlica","year":"2014","journal-title":"Viruses"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.chom.2013.10.012","article-title":"HIV-1 induces the formation of stable microtubules to enhance early infection","volume":"14","author":"Sabo","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.chom.2011.08.010","article-title":"Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore complex promote virus infection","volume":"10","author":"Strunze","year":"2011","journal-title":"Cell Host Microbe"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/j.celrep.2019.07.079","article-title":"FEZ1 Is Recruited to a Conserved Cofactor Site on Capsid to Promote HIV-1 Trafficking","volume":"28","author":"Huang","year":"2019","journal-title":"Cell Rep."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e41800","DOI":"10.7554\/eLife.41800","article-title":"HIV-1 nuclear import in macrophages is regulated by CPSF6-capsid interactions at the nuclear pore complex","volume":"8","author":"Bejarano","year":"2019","journal-title":"eLife"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/JVI.01899-09","article-title":"The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase","volume":"84","author":"Krishnan","year":"2010","journal-title":"J. Virol."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Ocwieja, K.E., Brady, T.L., Ronen, K., Huegel, A., Roth, S.L., Schaller, T., James, L.C., Towers, G.J., Young, J.A.T., and Chanda, S.K. (2011). HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1001313"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/s41564-019-0575-6","article-title":"Transportin-1 binds to the HIV-1 capsid via a nuclear localization signal and triggers uncoating","volume":"4","author":"Fernandez","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e00706","DOI":"10.1128\/JVI.00706-19","article-title":"A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing","volume":"93","author":"Siddiqui","year":"2019","journal-title":"J. Virol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature12769","article-title":"HIV-1 evades innate immune recognition through specific cofactor recruitment","volume":"503","author":"Rasaiyaah","year":"2013","journal-title":"Nature"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Balasubramaniam, M., Zhou, J., Addai, A., Martinez, P., Pandhare, J., Aiken, C., and Dash, C. (2019). PF74 Inhibits HIV-1 Integration by Altering the Composition of the Preintegration Complex. J. Virol., 93.","DOI":"10.1128\/JVI.01741-18"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Blanco-Rodriguez, G., Gazi, A., Monel, B., Frabetti, S., Scoca, V., Mueller, F., Schwartz, O., Krijnse-Locker, J., Charneau, P., and Di Nunzio, F. (2020). Remodeling of the core leads HIV-1 pre-integration complex in the nucleus of human lymphocytes. J. Virol., 94.","DOI":"10.1128\/JVI.00135-20"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1128\/JVI.00340-15","article-title":"HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry","volume":"89","author":"Zhou","year":"2015","journal-title":"J. Virol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"e02501","DOI":"10.1128\/mBio.02501-19","article-title":"Analysis of CA Content and CPSF6 Dependence of Early HIV-1 Replication Complexes in SupT1-R5 Cells","volume":"10","author":"Zila","year":"2019","journal-title":"mBio"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1128\/JVI.00019-16","article-title":"Capsid-CPSF6 Interaction Is Dispensable for HIV-1 Replication in Primary Cells but Is Selected during Virus Passage In Vivo","volume":"90","author":"Saito","year":"2016","journal-title":"J. Virol."},{"key":"ref_159","unstructured":"Sager, J., Begley, R., Rhee, M., West, S., Ling, J., Schroeder, S., Tse, W., and Mathias, A. (2019, January 4\u20137). Safety and PK of Suncutaneous GS-6207, a novel HIV-1 capsid inhibitor. Proceedings of the Conference on Retroviruses and Opportuinistic Infections, Abstract #141, Seattle, WA, USA."},{"key":"ref_160","unstructured":"Begley, R., Rhee, M., West, S., Worth, A., Ling, J., and German, P. (2020, January 8\u201311). PK, food effect, and safety of oral GS-6207, a novel HIV-1 capsid inhibitor. Proceedings of the Conference on Retroviruses and Opportunistic Infections, Abstract #470, Boston, MA, USA."},{"key":"ref_161","unstructured":"Daar, E., McDonald, C., Crofoot, G., Ruane, P., Sinclair, G., DeJesus, E., Berhe, M., Ramgopal, M., Patel, H., and Liu, Y. (2020, January 8\u201311). Dose-response relationship of subcutaneous long-acting HIV capsid inhibitor GS-6207. Proceedings of the Conference on Retroviruses and Opportunistic Infections, Abstract #469, Boston, MA, USA."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Bester, S., Wei, G., Zhao, H., Iqbal, N., Adu-Ampratwum, D., Francis, A.C., Annamalai, A., Singh, P., Morrison, J., and Poeschla, E. (2020, January 18\u201321). Structural and mechanistic basis for an ultra-potent HIV-1 capsid inhibitor. Proceedings of the Cold Spring Harbor\u2014Retroviruses, Abstract #95, Cold Spring Harbor, NY, USA.","DOI":"10.1126\/science.abb4808"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2174\/1568026043388547","article-title":"Structure and function of HIV-1 integrase","volume":"4","author":"Chiu","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0065-3527(08)60304-8","article-title":"HIV integrase structure and function","volume":"52","author":"Esposito","year":"1999","journal-title":"Adv. Virus Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"12730","DOI":"10.1021\/acs.chemrev.6b00125","article-title":"Retroviral DNA Integration","volume":"116","author":"Lesbats","year":"2016","journal-title":"Chem. Rev."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0065-3527(08)60309-7","article-title":"In vivo analysis of retroviral integrase structure and function","volume":"52","author":"Engelman","year":"1999","journal-title":"Adv. Virus Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1128\/JVI.76.9.4331-4340.2002","article-title":"The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein","volume":"76","author":"Hill","year":"2002","journal-title":"J. Virol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/JVI.73.3.2126-2135.1999","article-title":"Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex","volume":"73","author":"Wu","year":"1999","journal-title":"J. Virol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"17308","DOI":"10.1073\/pnas.0506924102","article-title":"Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75","volume":"102","author":"Cherepanov","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nm1329","article-title":"A role for LEDGF\/p75 in targeting HIV DNA integration","volume":"11","author":"Ciuffi","year":"2005","journal-title":"Nat. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1128\/JVI.78.17.9524-9537.2004","article-title":"LEDGF\/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes","volume":"78","author":"Llano","year":"2004","journal-title":"J. Virol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jmb.2006.04.073","article-title":"Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF\/p75","volume":"360","author":"Llano","year":"2006","journal-title":"J. Mol. Biol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1128\/JVI.80.4.1886-1896.2006","article-title":"Transient and stable knockdown of the integrase cofactor LEDGF\/p75 reveals its role in the replication cycle of human immunodeficiency virus","volume":"80","author":"Vandekerckhove","year":"2006","journal-title":"J. Virol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"25517","DOI":"10.1074\/jbc.M501378200","article-title":"Integrase mutants defective for interaction with LEDGF\/p75 are impaired in chromosome tethering and HIV-1 replication","volume":"280","author":"Emiliani","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1242\/jcs.02299","article-title":"Identification of the LEDGF\/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering","volume":"118","author":"Vanegas","year":"2005","journal-title":"J. Cell Sci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nchembio.370","article-title":"Rational design of small-molecule inhibitors of the LEDGF\/p75-integrase interaction and HIV replication","volume":"6","author":"Christ","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1021\/ml500002n","article-title":"Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1","volume":"5","author":"Fader","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Sharma, A., Slaughter, A., Jena, N., Feng, L., Kessl, J.J., Fadel, H.J., Malani, N., Male, F., Wu, L., and Poeschla, E. (2014). A new class of multimerization selective inhibitors of HIV-1 integrase. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004171"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1742-4690-10-144","article-title":"Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage","volume":"10","author":"Bonnard","year":"2013","journal-title":"Retrovirology"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/j.ddtec.2012.10.002","article-title":"Rational design of LEDGINs as first allosteric integrase inhibitors for the treatment of HIV infection","volume":"10","author":"Desimmie","year":"2013","journal-title":"Drug Discov. Today Technol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"16801","DOI":"10.1074\/jbc.M112.354373","article-title":"Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors","volume":"287","author":"Kessl","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_182","first-page":"93","article-title":"HIV-1 integrase multimerization as a therapeutic target","volume":"389","author":"Feng","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Gupta, K., Turkki, V., Sherrill-Mix, S., Hwang, Y., Eilers, G., Taylor, L., McDanal, C., Wang, P., Temelkoff, D., and Nolte, R.T. (2016). Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase. PLoS Biol., 14.","DOI":"10.1371\/journal.pbio.1002584"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/pro.2997","article-title":"Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studies","volume":"25","author":"Deng","year":"2016","journal-title":"Protein Sci. A Publ. Protein Soc."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Balakrishnan, M., Yant, S.R., Tsai, L., O\u2019Sullivan, C., Bam, R.A., Tsai, A., Niedziela-Majka, A., Stray, K.M., Sakowicz, R., and Cihlar, T. (2013). Non-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074163"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Madison, M.K., Lawson, D.Q., Elliott, J., Ozanturk, A.N., Koneru, P.C., Townsend, D., Errando, M., Kvaratskhelia, M., and Kutluay, S.B. (2017). Allosteric HIV-1 Integrase Inhibitors Lead to Premature Degradation of the Viral RNA Genome and Integrase in Target Cells. J. Virol., 91.","DOI":"10.1128\/JVI.00821-17"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"15137","DOI":"10.1074\/jbc.REV119.006901","article-title":"Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition","volume":"294","author":"Engelman","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_188","unstructured":"Ahn, S., Kim, U., Seo, W.Y., Choi, S., Maehigashi, T., Lindenberger, J., Kvaratskhelia, M., Kim, B., and Kim, K. (2020, January 8\u201311). A highly potent and safe allosteric HIV-1 integrase inhibitor, STP0404. Proceedings of the Conference on Retroviruses and Opportunistic Infections, Abstract #504, Boston, MA, USA."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/acsmedchemlett.6b00194","article-title":"Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs","volume":"7","author":"Fader","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1074\/jbc.M117.816793","article-title":"Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration","volume":"293","author":"Bonnard","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_191","first-page":"e01118","article-title":"Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes","volume":"93","author":"Singh","year":"2019","journal-title":"J. Virol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"8536","DOI":"10.1128\/JVI.00317-09","article-title":"A Strongly Transdominant Mutation in the Human Immunodeficiency Virus Type 1 Gag Gene Defines an Achilles Heel in the Virus Life Cycle","volume":"83","author":"Lee","year":"2009","journal-title":"J. Virol."},{"key":"ref_193","first-page":"537","article-title":"Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein","volume":"9","author":"Tang","year":"2002","journal-title":"Nat. Struct. Biol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/9\/940\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:06:45Z","timestamp":1760177205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/9\/940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":193,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["v12090940"],"URL":"https:\/\/doi.org\/10.3390\/v12090940","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]}}}